Van Tine, B. A., Ingham, M. A., Attia, S., Meyer, C. F., Baird, J. D., Brooks-Asplund, E., D’Silva, D., Kong, R., Mwatha, A., O’Keefe, K., Weetall, M., Spiegel, R., & Schwartz, G. K. (2024). Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of Clinical Oncology, 42(20), 2404–2414. https://doi.org/10.1200/jco.23.01684